Task: Answer the multiple-choice question.
Query: Which drug has a -3.210% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) OC(CN1CCN(c2ccc(F)cc2)CC1)c1ccc(Cl)cc1
b.) CCOC(=O)[C@@H]1[C@H]2COc3cc(OC)ccc3[C@@H]2N2C(=O)N(c3ccc(C(F)(F)F)cc3)C(=O)[C@@]12C
c.) CCNc1nc(NCC)nc(N(C#N)C(C)C)n1
Answer: c. CCNc1nc(NCC)nc(N(C#N)C(C)C)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCNc1nc(NCC)nc(N(C#N)C(C)C)n1
CCNc1nc(NCC)nc(N(C#N)C(C)C)n1
[4,6-bis(ethylamino)-1,3,5-triazin-2-yl]-propan-2-ylcyanamide